drugset / Trial / NCT02259816

Pharmacokinetics of Telmisartan Alone and in Combination With Amlodipine in Healthy Volunteers

NCT02259816

Phase 1 Completed 38 enrolled Boehringer Ingelheim
RandomizedCrossoverOpen-labelTreatment

Summary

Study to investigate the steady state pharmacokinetics of 80 mg telmisartan alone and in combination with repeated doses of 10 mg amlodipine

Timeline

Start
2006-05
Primary completion
2006-08
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 10 mg Oral
Subject Telmisartan Other / unclassified 80 mg Oral

Indications

No indication recorded.